Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Matinas Biopharma (6LJ0.F) Q2 2025 Earnings
6LJ0.F
15
Apr
Confirmed
Q3 2024
Q4 2024
Q2 2025
-1.14
-0.99
-0.84
-0.69
Details
Expected EPS
-0.690534
Actual EPS
N/A
Surprise EPS
0.69
Surprise Percent
+100%
Description
Matinas Biopharma (6LJ0.F) will report earnings of for Q2 2025 on April 15, 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login